​

Bicycle Therapeutics Ownership | Who Owns Bicycle Therapeutics?

OverviewForecastRevenueFinancialsChart

Bicycle Therapeutics Ownership Summary

Bicycle Therapeutics is owned by 58.62% institutional investors, 1.30% insiders, and 40.08% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 22.09% of BCYC shares. T. Rowe Price Health Sciences is the top mutual fund, with 1.93% of its assets in Bicycle Therapeutics shares.

BCYC Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockBicycle Therapeutics58.62%1.30%40.08%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Baker bros. advisors lp9.40M22.09%$190.26M
Deep track capital, lp3.49M8.20%$70.65M
Ra capital management2.25M5.29%$45.60M
Fcpm iii services b.v.2.12M4.99%$42.97M
Armistice capital1.97M4.63%$39.91M
Westfield capital management co lp1.52M3.58%$30.84M
Tybourne capital management (hk)1.51M3.55%$30.56M
First light asset management1.38M3.25%$28.03M
Morgan stanley1.23M2.89%$24.93M
Fairmount funds management1.07M2.51%$21.64M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Fcpm iii services b.v.2.12M6.34%$42.97M
Tybourne capital management (hk)1.51M6.21%$30.56M
Aquilo capital management156.69K3.06%$3.17M
First light asset management1.38M2.46%$28.03M
Fairmount funds management1.07M2.44%$21.64M
Baker bros. advisors lp9.40M2.43%$190.26M
Deep track capital, lp3.49M2.11%$70.65M
Parkman healthcare partners535.06K1.45%$10.83M
Highvista strategies127.25K0.94%$2.58M
Alphacentric advisors60.00K0.89%$1.21M

Top Buyers

HolderShares% AssetsChange
Baker bros. advisors lp9.40M2.43%4.46M
Fcpm iii services b.v.2.12M6.34%2.12M
Ra capital management2.25M0.60%1.45M
Fairmount funds management1.07M2.44%1.07M
Ecor1 capital910.00K0.56%910.00K

Top Sellers

HolderShares% AssetsChange
Paradigm biocapital advisors lp---3.25M
Suvretta capital management---914.48K
Avoro capital advisors---700.00K
Woodline partners lp---586.62K
Morgan stanley1.23M0.00%-285.14K

New Positions

HolderShares% AssetsChangeValue
Fcpm iii services b.v.2.12M6.34%2.12M$42.97M
Fairmount funds management1.07M2.44%1.07M$21.64M
Ecor1 capital910.00K0.56%910.00K$18.42M
Perceptive advisors572.00K0.27%572.00K$11.58M
Aquilo capital management156.69K3.06%156.69K$3.17M

Sold Out

HolderChange
Zurcher kantonalbank (zurich cantonalbank)-4.00
Mather group, llc.-5.00
Northwestern mutual wealth management-5.00
Gen-wealth partners-39.00
Group one trading-91.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241101.85%40,440,4271.84%581.00%55-9.84%3228.00%
Jun 30, 202410711.46%39,708,44130.36%931.81%6042.86%25-24.24%
Mar 31, 202496-10.28%30,461,275-2.88%711.14%42-25.00%333.13%
Dec 31, 20231072.88%31,365,344-3.19%790.69%56-6.67%3239.13%
Sep 30, 202310418.18%32,400,07633.05%1071.63%6053.85%23-17.86%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
T. Rowe Price Health Sciences1.33M1.93%33.87K
Polar Capital Biotech S Inc1.00M1.45%-
Harbor Small Cap Growth Instl847.47K1.23%151.69K
Westfield Capital Mgt Co Sm-Cap Gr Eq695.78K1.01%234.44K
Candriam Eqs L Biotech C USD Cap558.46K0.81%103.02K
BNP Paribas Health Cr Innovtr Cl Cap524.80K0.76%-70.78K
Candriam Global Equities Oncology492.11K0.71%125.18K
Belfius Equities Cure C Cap492.11K0.71%-
AXA Framlington Health Fund - R Income273.98K0.40%-
iShares Biotechnology ETF272.78K0.40%-1.63K

Recent Insider Transactions

DateNameRoleActivityValue
Dec 13, 2024BAKER BROS. ADVISORS LP Buy$3.36M
Dec 13, 2024BAKER BROS. ADVISORS LP Buy$817.66K
Dec 16, 2024BAKER BROS. ADVISORS LP Buy$7.02M
Dec 13, 2024BAKER BROS. ADVISORS LP Buy$7.82M
Dec 13, 2024BAKER BROS. ADVISORS LP Buy$408.19K

Insider Transactions Trends

DateBuySell
2024 Q41011
2024 Q3-7
2024 Q2-7
2024 Q1-6
2023 Q4-6

BCYC Ownership FAQ

Who Owns Bicycle Therapeutics?

Bicycle Therapeutics shareholders are primarily institutional investors at 58.62%, followed by 1.30% insiders and 40.08% retail investors. The average institutional ownership in Bicycle Therapeutics's industry, Biotech Stocks , is 47.04%, which Bicycle Therapeutics exceeds.

Who owns the most shares of Bicycle Therapeutics?

Bicycle Therapeutics’s largest shareholders are Baker bros. advisors lp (9.4M shares, 22.09%), Deep track capital, lp (3.49M shares, 8.20%), and Ra capital management (2.25M shares, 5.29%). Together, they hold 35.58% of Bicycle Therapeutics’s total shares outstanding.

Does Blackrock own Bicycle Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Bicycle Therapeutics.

Who is Bicycle Therapeutics’s biggest shareholder by percentage of total assets invested?

Fcpm iii services b.v is Bicycle Therapeutics’s biggest shareholder by percentage of total assets invested, with 6.34% of its assets in 2.12M Bicycle Therapeutics shares, valued at 42.97M$.

Who is the top mutual fund holder of Bicycle Therapeutics shares?

T. Rowe Price Health Sciences is the top mutual fund holder of Bicycle Therapeutics shares, with 1.93% of its total shares outstanding invested in 1.33M Bicycle Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools